The Asia Pacific Endometrial Ablation Market would witness market growth of 7.0% CAGR during the forecast period (2018 – 2024).
Endometrial ablation is used in facilitating the destruction of endometrium or thin layer of the uterine wall, and is used in treating abnormal heavy uterine bleeding. Prolonged abnormal uterine bleeding could lead to low blood count and anemia. Endometrial ablation is a technique that has gained prominence as there is no need for incisions, and the technique is very popular among women suffering menstrual problems. Asia Pacific is the region with tremendous market potential, offering lucrative opportunities to market players. Growing prevalence of gynecological disorders due to limited awareness and poor standards of hygiene and high unmet medical needs would drive the demand for endometrial ablation procedures in this region.
Based on the Technology, the Endometrial Ablation market is segmented into Radiofrequency Ablation, Cryoablation, Hydrothermal Ablation, Thermal Balloon, Hysteroscopic Ablation, and Others. Based on the end user, the market is segmented into Hospitals, Clinics, and Ambulatory Surgical Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew Plc., Olympus Corporation, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Ethicon, LLC. (Johnson & Johnson), Medtronic Plc., Hologic Corporation, Minerva Surgical, Inc., The Cooper Companies, Inc. (Cooper Surgical Inc.), AngioDynamics Inc.
Scope of the Study
Market Segmentation:
By Technology
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
